Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis.
暂无分享,去创建一个
Tieying Hou | Yu Zhang | Dehong Huang | Zhiming Ye | R. Zeng
[1] Q. Zou,et al. Presepsin as a novel sepsis biomarker. , 2014, World journal of emergency medicine.
[2] S. Kingsmore,et al. Discriminative value of inflammatory biomarkers for suspected sepsis. , 2012, The Journal of emergency medicine.
[3] Charles B Cairns,et al. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. , 2010, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[4] C. Haasper,et al. Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. , 2010, Technology and health care : official journal of the European Society for Engineering and Medicine.
[5] P. Reitsma,et al. Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department , 2010, Critical care medicine.
[6] N. Voirin,et al. Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients , 2009, Intensive Care Medicine.
[7] Huang-Pin Wu,et al. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.
[8] C. Woods,et al. Sepsis redefined: the search for surrogate markers. , 2009, International journal of antimicrobial agents.
[9] M. Meisner,et al. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia , 2008, Intensive Care Medicine.
[10] M. Levy,et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.
[11] M. Levy,et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.
[12] D. Hu,et al. Study on the relationship of APACHE III and levels of cytokines in patients with systemic inflammatory response syndrome after coronary artery bypass grafting. , 2007, Biological & pharmaceutical bulletin.
[13] Jih-Chang Chen,et al. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study , 2003, Critical care.
[14] R. Brilli,et al. Coagulation dysfunction in sepsis and multiple organ system failure. , 2003, Critical care clinics.
[15] M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.
[16] V. Pettilä,et al. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis , 2002, Intensive Care Medicine.
[17] J. Bertrand,et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines , 2000, Intensive Care Medicine.
[18] K. Reinhart,et al. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. , 1999, Critical care medicine.
[19] R. Bone,et al. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. , 1996, Critical care medicine.
[20] J. Sjölin,et al. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. , 1995, The Journal of infectious diseases.
[21] K. Deen,et al. Interleukin 6 is a prognostic indicator of outcome in severe intra‐abdominal sepsis , 1994, The British journal of surgery.